Glycogenic hepatopathy - An underrecognized hepatic complication of diabetes mellitus

被引:146
|
作者
Torbenson, M
Chen, YY
Brunt, E
Cummings, OW
Gottfried, M
Jakate, SHA
Liu, YC
Yeh, MM
Ferrell, L
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA
[2] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA
[3] St Louis Univ, Sch Med, Dept Pathol, Ctr Liver, St Louis, MO USA
[4] Indiana Univ, Sch Med, Dept Pathol, Indianapolis, IN 46204 USA
[5] Duke Univ, Med Ctr, Dept Pathol, Durham, NC USA
[6] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA
[7] Case Western Reserve Univ, Dept Pathol, MetroHlth Med Ctr, Cleveland, OH 44106 USA
[8] Univ Washington, Med Ctr, Dept Pathol, Seattle, WA 98195 USA
关键词
glycogen; glycogenosis; diabetes mellitus; hepatomegaly; Mauriac syndrome;
D O I
10.1097/00000478-200604000-00012
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Reported are the clinical and pathologic features of glycogenic hepatopathy, a pathologic overloading of hepatocytes with glycogen that is associated with poorly controlled diabetes mellitus. Fourteen cases were Studied by stains, including hematoxylin and eosin, trichrome, periodic acid-Schiff, and periodic acid-Schiff with diastase. Ultrastructural analysis was performed in 2 cases. Medical records were reviewed for clinical presentations, laboratory findings, and clinical outcomes. The individuals ranged from 8 to 25 years of age All had type I diabetes mellitus with poor glycemic control. The clinical presentations included hepatomegaly, abdominal pain, and elevated transaminases (range, 50-16001U/L). The transaminases were dramatically elevated in 3 cases to greater than 10 times the upper limit of normal. All biopsies showed diffusely pale staining hepatocytes on hematoxylin and eosin stains, with excessive glycogen accumulation demonstrated by periodic acid-Schiff stains. Ultrastructural examination revealed marked glycogen accumulation in the cytoplasm and nuclei. Most cases showed no evidence for fatty liver disease: steatosis was absent in 12 of 14 cases, simple steatosis was seen in I of 14 cases, and mild steatohepatitis was present in I of 14 cases. Mallory hyaline was absent in all cases, acidophil bodies were only rarely seen, and inflammation was absent or minimally present. Fibrosis was typically absent, with only 2 cases demonstrating focal mild fibrosis. Three patients had adequate follow-up and demonstrated improvement of liver enzyme levels with control of blood glucose. We conclude that glycogenic hepatopathy can cause hepatomegaly and significant transaminase elevations in individuals with type I diabetes mellitus. The pathology is distinct from steatohepatitis.
引用
收藏
页码:508 / 513
页数:6
相关论文
共 50 条
  • [31] Glycogenic hepatopathy as a cause of severe deranged liver enzymes in a young patient with type 1 diabetes mellitus
    Azariadis, Kalliopi
    Gatselis, Nikolaos K.
    Koukoulis, George K.
    Dalekos, Georgios N.
    BMJ CASE REPORTS, 2019, 12 (03)
  • [32] Glycogenic hepatopathy is associated with type 1 diabetes mellitus in only a minority of cases in a contemporary adult population
    Cox, Brian K.
    Guindi, Maha
    Hutchings, Danielle
    Kim, Stacey A.
    Waters, Kevin M.
    Larson, Brent K.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2023, 64
  • [33] Liver function tests and pattern of hepatic injury in glycogenic hepatopathy associated with insulin-dependent diabetes mellitus: A systematic review and analysis of 172 cases
    Bazerbachi, Fateh
    Haffar, Samir
    Leise, Michael D.
    Sharma, Ayush
    Mukewar, Saurabh
    Sugihara, Takaaki
    Murad, Mohammad H.
    Watt, Kymberly D.
    HEPATOLOGY, 2017, 66 : 441A - 441A
  • [34] Hepatic glycogenosis: An underdiagnosed complication of diabetes mellitus?
    Teresa Julian, Maria
    Alonso, Nuria
    Ojanguren, Isabel
    Pizarro, Eduarda
    Ballestar, Enric
    Puig-Domingo, Manel
    WORLD JOURNAL OF DIABETES, 2015, 6 (02): : 321 - 325
  • [35] Glycogenic hepatopathy is an under-recognised cause of hepatomegaly and elevated liver transaminases in type 1 diabetes mellitus
    Irani, N. R.
    Venugopal, K.
    Kontorinis, N.
    Lee, M.
    Sinniah, R.
    Bates, T. R.
    INTERNAL MEDICINE JOURNAL, 2015, 45 (07) : 777 - 779
  • [36] Glycogenic hepatopathy: A narrative review
    Jagannath M Sherigar
    Joline De Castro
    Yong Mei Yin
    Debra Guss
    Smruti R Mohanty
    World Journal of Hepatology, 2018, (02) : 172 - 185
  • [37] Glycogenic Hepatopathy: A Reversible Condition
    Haider, Fyeza
    Smith, Robert
    Babameto, Genci
    Kotru, Anil
    Raza, Naeem
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S277 - S278
  • [38] Glycogenic hepatopathy: A narrative review
    Sherigar, Jagannath M.
    De Castro, Joline
    Yin, Yong Mei
    Guss, Debra
    Mohanty, Smruti R.
    WORLD JOURNAL OF HEPATOLOGY, 2018, 10 (02) : 172 - 185
  • [39] Glycogenic Hepatopathy With Persistent Hepatomegaly in a Patient With Uncontrolled Type 1 Diabetes
    Kant, Ravi
    Loper, Hillary B.
    Verma, Vipin
    Malek, Rana
    Drachenberg, Cinthia B.
    Munir, Kashif M.
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2015, 5 (1-2) : 189 - 191
  • [40] The Bright Liver of Glycogenic Hepatopathy
    Sweetser, Seth
    Kraichely, Robert E.
    HEPATOLOGY, 2010, 51 (02) : 711 - 712